老年人慢性便秘的药物治疗进展
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

上海市卫生局课题(20114316)


Chronic constipation in the elderly: advances in medication treatment
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    慢性便秘是老年人最常见的消化道症状之一,不仅影响老年人的生活质量,也存在诱发或加重其他疾病的危险性。老年人慢性便秘的病因复杂,治愈难度大,目前主要是根据便秘的病因、分类及其严重程度进行综合治疗,常见的治疗方法包括调整生活方式、药物治疗、精神心理治疗、手术治疗及生物反馈等。本文针对近年来国内外老年人慢性便秘药物治疗进展, 尤其是5-羟色胺受体激动剂、鸟苷酸环化酶C受体激动剂、氯离子通道激活剂、阿片μ受体拮抗剂等新型药物的疗效及安全性进行综述。

    Abstract:

    As one of the most common gastrointestinal symptoms in the elderly, chronic constipation (CC) not only affects the seniors’ life quality, but also aggravates the risk of other diseases. Because of the complicated pathogenesis, CC in the elderly is difficult to cure. At present, comprehensive treatment is mainly based on the causes, classification and severity. Common treatments include adjusting life style, medication, psychological treatment, surgical treatment, biofeedback, etc. In this paper, the recent advances in the medication of CC in the elderly were reviewed, especially on the efficacy and safety of new drugs, such as 5-hydroxytryptamine (5-HT) receptor agonist, guanylate cyclase C agonist, chlorine ion channel activator, mu-opioid receptor antagonist, and so on.

    参考文献
    相似文献
    引证文献
引用本文

李青青,江 华*.老年人慢性便秘的药物治疗进展[J].中华老年多器官疾病杂志,2014,13(03):182~

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-04-02
  • 出版日期: